Q1 revenue of $21.9 million, increasing 11% year-over-yearQ1 gross profit increased 9% year-over-year to $13.3 millionIncreases full year 2025 guidance to a revenue range between $101 million and $106 million and adjusted EBITDA range between $13 million and $15 million WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and pati ...

SEATTLE, May 12, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the BofA Securities 2025 Healthcare Conference at 9:20 a.m. PT on Tuesday, May 13, 2025. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. The webcast will be accessible on the Investor Relations page of Sana’s website ...

Beyond Oil Receives C$2.166M in Warrant Exercise Proceeds from 1,836,766 WarrantsVANCOUVER, BC and KIBBUTZ YIFAT, Israel, May 12, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation company dedicated to reducing health risks associated with fried food while lowering operational costs, minimizing waste, and enhancing sustainability, today announced that members of the Or family have exercised a total of 1,836,766 warrant ...

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of May: H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq, May 20 in New York City. Management will be holding one-on-one meetings with investors.B. Riley Securities 25th Annual Institutional Investor Conference, May 21-22 at the Ritz-Carlton in Marina Del Rey ...

HOUSTON, May 12, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (NYSE: AMPY) (“Amplify,” the “Company,” “us,” or “our”) announced today its operating and financial results for the first quarter of 2025 and updated full-year 2025 guidance for the Company. Beta Development Program Update Amplify initiated a development drilling program in the prolific Beta oilfield in 2024 to demonstrate the significant upside potential of the asset and generate strong incremental cash flows for the Company, with results to da ...

Announced Boehringer Ingelheim strategic collaboration and license agreement for CUE-501, including an upfront payment of $12 million and ~$345 million in potential milestone payments Raised gross proceeds of ~$20 million in follow-on capital raise Successfully regained worldwide rights for lead autoimmune program, CUE-401, with potential to become a new standard of care for autoimmune and inflammatory diseases Virtual Event planned for May 15, 2025 at 11 AM ET, featuring two prominent Key Opinion Leaders i ...

Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected to participate in clinical trialTen globally leading transplant hospitals are now using our GraftAssure research-use-only kitsTo reflect our larger market opportunity, we plan to rename the company in Q2 IRVINE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with i ...

Clinical data on track for Q4 2025 from Phase 2 trial of BDTX-1535 in 1L patients with non-classical EGFRm NSCLCExpansion of investigator sponsored Phase 0/1 trial into newly diagnosed glioblastoma patients with EGFR alterations initiated in Q1 2025Cash, cash equivalents, and investments of $152.4 million as of March 31, 2025; expected to be sufficient to fund operations into Q4 of 2027 CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncol ...

Net Income Rises to $1.3 Million Bookings Up 120% Year Over Year to $6.4 Million CHANDLER, Ariz., May 12, 2025 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators and firearms training simulators for the law enforcement and military markets, reported results for the first quarter ended March 31, 2025. The financial statements are available on VirTra’s website and here. First Quarter 2025 and Recent Operational Highligh ...

Core Viewpoint - GigaCloud Technology Inc continues to demonstrate resilience and growth in its B2B marketplace despite industry challenges, driven by the effectiveness of its Supplier Fulfilled Retailing (SFR) model [4][6]. Financial Highlights - Total revenues for Q1 2025 reached $271.9 million, an increase of 8.3% year-over-year [6]. - Gross profit was $63.7 million, down 4.2% year-over-year, resulting in a gross margin of 23.4%, compared to 26.5% in Q1 2024 [6]. - Net income was $27.1 million, consistent with the prior year's figure, yielding a net income margin of 10.0% [6]. - Diluted EPS increased by 3.0% year-over-year to $0.68 [6]. - Adjusted EBITDA for the quarter was $33.2 million, a decrease of 3.8% year-over-year [6]. Operational Highlights - GigaCloud Marketplace GMV grew by 56.1% year-over-year to $1,416.7 million for the 12 months ending March 31, 2025 [6]. - GMV from 3P sellers increased by 49.9% year-over-year to $734.3 million, representing 51.8% of total GMV [6]. - Active 3P sellers rose by 33.4% year-over-year to 1,154, while active buyers surged by 81.4% to 9,966 [6]. Share Repurchase Program - The Board approved a share repurchase program initially set at $46 million, later increased to $62 million in March 2025, and further raised to $78 million in May 2025 [7][8]. - Approximately 3.7 million shares have been repurchased for $61.8 million, representing nearly 150% of the gross proceeds from the IPO [4][7]. Business Outlook - The company anticipates total revenues between $275 million and $305 million for Q2 2025, reflecting current market conditions [5].